LCS
DRTS icon

Levin Capital Strategies’s Alpha Tau Medical DRTS Stock Holding History

Levin Capital Strategies’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
128,594
+22,171
+21% +$201K 0.11% 114
2026
Q1 		$752K Sell
106,423
-75,808
-42% -$535K 0.06% 129
2025
Q4 		$902K Sell
182,231
-22,483
-11% -$94.8K 0.08% 95
2025
Q3 		$923K Buy
204,714
+12,200
+6% +$41.5K 0.08% 95
2025
Q2 		$601K Sell
192,514
-30,000
-13% -$84.5K 0.06% 113
2025
Q1 		$559K Sell
222,514
-92,000
-29% -$288K 0.06% 107
2024
Q4 		$975K Buy
314,514
+7,189
+2% +$18.4K 0.09% 91
2024
Q3 		$731K Buy
307,325
+26,866
+10% +$59.5K 0.07% 110
2024
Q2 		$710K Sell
280,459
-58,305
-17% -$148K 0.07% 99
2024
Q1 		$999K Buy
338,764
+8,641
+3% +$26.5K 0.1% 97
2023
Q4 		$994K Buy
330,123
+245,123
+288% +$789K 0.11% 93
2023
Q3 		$322K Buy
85,000
+65,000
+325% +$238K 0.04% 182
2023
Q2 		$87.4K Buy
+20,000
New +$71.7K 0.01% 247

Other funds holding DRTS

GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Levin Capital Strategies's DRTS Position: Q2 2026 in Review

Levin Capital Strategies increased its Alpha Tau Medical (DRTS) stake by 21% in Q2 2026, buying an estimated $201K and bringing the position to 128,594 shares worth $1.62M. The position accounts for 0.11% of the portfolio, ranked #114.

Levin Capital Strategies first reported a position in DRTS in Q2 2023 and has held it in 13 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Levin Capital Strategies held 128,594 shares of Alpha Tau Medical worth $1.62M as of Q2 2026.
  • Levin Capital Strategies bought 22,171 Alpha Tau Medical shares in Q2 2026, an estimated $201K.
  • Alpha Tau Medical made up 0.11% of Levin Capital Strategies's portfolio in Q2 2026, its #114 holding.
  • Levin Capital Strategies first reported a position in Alpha Tau Medical in Q2 2023 and has held it in 13 quarters since.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Levin Capital Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.